clinical trials

Regulators are highlighting the need for a comprehensive international coordination mechanism to allow the conduct of adequately powered, randomised controlled trials, which can generate sound evidence on the effects of therapeutics or vaccines against COVID-19. This follows a call made by EMA’s Human Medicines Committee (CHMP) for the research community to pool resources into large, well-designed, multi-arm clinical […]